Literature DB >> 10716883

The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis.

A Craxton1, P I Chuang, G Shu, J M Harlan, E A Clark.   

Abstract

CD40 activation is necessary for thymus-dependent humoral immune responses and rescuing both phenotypically immature WEHI-231 B lymphoma cells from B cell antigen receptor-induced cell death and germinal center B cells from spontaneous apoptosis. As some effects of CD40 are probably mediated by differences in gene expression, cDNA expression arrays and RNase protection assays were used to identify the anti-apoptotic Bcl-2 homolog A1 as a CD40-inducible gene in B cell lines and purified germinal center B cells. Sustained CD40-induced A1 upregulation correlated with CD40-mediated rescue of WEHI-231 cells from anti-IgM-induced apoptosis. Moreover, overexpression of A1 specifically protected WEHI-231 cells from anti-IgM-induced apoptosis but not cell death triggered by certain other stimuli. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716883     DOI: 10.1006/cimm.2000.1616

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

Review 1.  Life and death within germinal centres: a double-edged sword.

Authors:  Liliana Guzman-Rojas; Jennifer C Sims-Mourtada; Roberto Rangel; Hector Martinez-Valdez
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 2.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

3.  The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire.

Authors:  Genita Metzler; Xuezhi Dai; Christopher D Thouvenel; Socheath Khim; Tania Habib; Jane H Buckner; David J Rawlings
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

4.  Regulation of memory B-cell survival by the BH3-only protein Puma.

Authors:  Cyril Clybouw; Silke Fischer; Marie Thérèse Auffredou; Patricia Hugues; Catherine Alexia; Philippe Bouillet; Martine Raphael; Gérald Leca; Andreas Strasser; David M Tarlinton; Aimé Vazquez
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

5.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Biochemical, pathological and oncological relevance of Gb3Cer receptor.

Authors:  D Đevenica; V Čikeš Čulić; A Vuica; A Markotić
Journal:  Med Oncol       Date:  2010-11-11       Impact factor: 3.064

7.  The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.

Authors:  Karin Tarte; Michel Jourdan; Jean Luc Veyrune; Ingolf Berberich; Geneviève Fiol; Nicole Redal; John Shaughnessy; Bernard Klein
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

8.  Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Authors:  Hai-Jun Zhou; Lan V Pham; Archito T Tamayo; Yen-Chiu Lin-Lee; Lingchen Fu; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2007-06-13       Impact factor: 22.113

9.  Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

Authors:  Brendan N D'Souza; Leonard C Edelstein; Pamela M Pegman; Sinéad M Smith; Sinéad T Loughran; Ann Clarke; Anja Mehl; Martin Rowe; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  AUF1 is involved in splenic follicular B cell maintenance.

Authors:  Navid Sadri; Jin-Yu Lu; Michelle L Badura; Robert J Schneider
Journal:  BMC Immunol       Date:  2010-01-11       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.